Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Chubb
UBS
US Department of Justice
Chinese Patent Office

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 6,524,852

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,524,852
Title: Removing or increasing permeability of embryonic capsule to prepare equine embryos for cryopreservation
Abstract:A method for preparing an equine embryo for cryopreservation is provided. The method includes collecting an equine embryo with its embryonic capsule. Then after collection the embryo is treated to eliminate or increase the permeability of the capsule in which to enhance subsequent action of cryoprotectant(s). After the treatment the embryo is contacted with cryoprotectant(s) and then placed in a straw with the cryoprotectant(s). Furthermore, the capsule can be treated with enzymes such as collagenase and/or trypsin. Also the embryonic capsule may be removed by mechanical means before subjecting it to the action of cryoprotectant(s). The embryo may also be subjected to an enzymatic treatment to weaken the capsule.
Inventor(s): Legrand; Emmanuel (61200 Sevigny, FR)
Assignee: Legrand; Emmanuel (Sevigny, FR) Legrand; Rene (Sevigny, FR) Legrand; Odile (Sevigny, FR) Legrand; Richard (Sevigny, FR) Legrand; Jean-Pierre (Sevigny, FR) Buisson; Corinne Legrand (Bailleul, FR)
Application Number:09/445,740
Patent Claims:see list of patent claims

Details for Patent 6,524,852

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Sign Up Legrand; Emmanuel (Sevigny, FR) Legrand; Rene (Sevigny, FR) Legrand; Odile (Sevigny, FR) Legrand; Richard (Sevigny, FR) Legrand; Jean-Pierre (Sevigny, FR) Buisson; Corinne Legrand (Bailleul, FR) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Boehringer Ingelheim
Chubb
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.